Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation
- Bing Xiao*,
- James Spencer*,
- Adrienne Clements†,
- Nadeem Ali-Khan*,
- Sibylle Mittnacht‡,
- Cristina Broceño‡,
- Manfred Burghammer§,
- Anastassis Perrakis¶,
- Ronen Marmorstein†, and
- Steven J. Gamblin*,‖
- *Division of Protein Structure, National Institute for Medical Research, Mill Hill, London NW7 1AA, United Kingdom; †Structural Biology Program, The Wistar Institute, and Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA 19104-4268; ‡Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, United Kingdom; §European Synchrotron Radiation Facility, B.P. 220, 38043 Grenoble Cedex, France; and ¶Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands
-
Edited by Stephen C. Harrison, Children's Hospital, Boston, MA, and approved December 30, 2002 (received for review November 8, 2002)
Abstract
The retinoblastoma tumor suppressor protein (pRb) regulates the cell cycle, facilitates differentiation, and restrains apoptosis. Furthermore, dysfunctional pRb is thought to be involved in the development of most human malignancies. Many of the functions of pRb are mediated by its regulation of the E2F transcription factors. To understand the structural basis for this regulation, we have determined the crystal structure of a fragment of E2F in complex with the pocket domain of the tumor suppressor protein. The pRb pocket, comprising the A and B cyclin-like domains, is the major focus of tumourigenic mutations in the protein. The fragment of E2F used in our structural studies, residues 409–426 of E2F-1, represents the core of the pRb-binding region of the transcription factor. The structure shows that E2F binds at the interface of the A and B domains of the pocket making extensive interactions with conserved residues from both. We show by solution studies that a second site, probably contained within the “marked box” region of E2F, is responsible for additional interactions with the pRb pocket but is insufficient for complex formation on its own. In addition, we show that the interaction of the core binding fragment of E2F with pRb is inhibited by phosphorylation of the tumor suppressor protein by CDK2/cyclin D/E. Finally, our data reveal that the tight binding of the human papillomavirus E7 oncoprotein to pRb prevents subsequent interactions with the marked box region of E2F but not with its core binding region.
Footnotes
-
↵ ‖ To whom correspondence should be addressed. E-mail: sgambli{at}nimr.mrc.ac.uk.
-
This paper was submitted directly (Track II) to the PNAS office.
-
Data deposition: The coordinates and structure factors reported in this paper have been deposited in the Protein Data Bank, www.rcsb.org (PDB ID code 1o9k).
-
See commentary on page 2165.
- Abbreviations:
- pRb,
- retinoblastoma tumor suppressor;
- HPV,
- human papillomavirus;
- ITC,
- isothermal titration calorimetry
- Copyright © 2003, The National Academy of Sciences





